UMOD and myeloid sarcoma: The authors propose that additional research is necessary to clarify the interplay between sUmod levels and MS, specifically whether the drop in sUmod levels (which suggests tubular injury) is a sign of a reduced renal reserve brought on by a decrease in nephron mass or if some other aspect of MS is affecting uromodulin biosynthesis [46].